Active, not recruitingNot applicableNCT05776667
Feasibility Trial of Preoperative 5-Day Hypofractionated Radiotherapy for Primary Soft Tissue Sarcoma
Studying OBSOLETE: Pleomorphic undifferentiated sarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Medical University of South Carolina
- Intervention
- Hypofractionated Radiation Therapy(radiation)
- Enrollment
- 16 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Medical University of South Carolina, Charleston, South Carolina, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05776667 on ClinicalTrials.govOther trials for OBSOLETE: Pleomorphic undifferentiated sarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07049848SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue SarcomaM.D. Anderson Cancer Center
- ACTIVE NOT RECRUITINGPHASE1NCT05813327Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue SarcomaWashington University School of Medicine
- RECRUITINGNANCT05944913Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After RadiotherapyCentre Leon Berard
- RECRUITINGPHASE3NCT05597917tTF-NGR Randomized Study - STSUniversität Münster
- RECRUITINGNANCT04946357Neoadjuvant Irradiation of Extremity Soft Tissue Sarcoma With IonsUniversity Hospital Heidelberg
See all trials for OBSOLETE: Pleomorphic undifferentiated sarcoma →